Maen Abdelrahim, Professor of Medicine, Chief of GI Medical Oncology, Medical Director of CCAT Phase I Center, Houston Methodist, shared a post on LinkedIn:
“I am glad to see our work highlighted at Nature. Utility of ctDNA post liver transplant is a new and evolving prognostic biomarker.”
Other articles about ctDNA on OncoDaily.